Prescription drug prices, like so many other expenses most households face every month, have been too high for too long. We’ve been asked to believe big-government solutions would work to bring prices down. Yet all the “best intentions” of federal bureaucrats have failed to produce results. In fact, asking the federal government to run any significant part of our lives is usually the pathway to disappointment and regret. But that doesn’t mean we don’t have other, better options.
In the 2024 presidential elections, it would be a mistake for any candidate, regardless of their ideology, to concede ground on this issue. Drug prices should be a focal point of next year’s campaigns for at least three reasons. One, the American people need relief. Two, we know that the Inflation Reduction Act isn’t actually going to make medications more affordable for the average Iowan. Three, some individual states have identified solutions that lower out-of-pocket costs without relying on heavy-handed big government solutions.
Comments